{
  "patent_number": "US 20240408251",
  "country": "US",
  "title": "Tiny Drug Carriers for Better Brain Tumor Treatment",
  "original_title": "Compositions and methods for targeted particle penetration, distribution, and response in malignant brain tumors",
  "summary": "This patent describes super-small nanoparticle drug conjugates designed to sneak past barriers and spread evenly inside tough-to-treat tumors, especially in the brain, for more effective cancer therapy.",
  "what_it_does": "This patent describes a method for treating cancer using special tiny drug carriers called nanoparticle drug conjugates (NDCs). Each NDC has a nanoparticle, which is super small—no bigger than 20 nanometers in average diameter, and ideally between 3 to 8 nanometers (Claim 1, Claim 5). Attached to this nanoparticle is a 'linker-drug construct' where a drug is connected by a 'cleavable linker' (Claim 1). This linker can break apart, releasing the drug once it reaches the tumor (Claim 6). The key is that these NDCs are designed to easily spread and move around within the tumor tissue, called the 'tumor interstitium' (Claim 1). For example, these NDCs could carry a chemotherapy drug like gefitinib (Claim 9) directly into a glioblastoma multiforme (GBM) brain tumor (Claim 2), allowing the drug to reach more cancer cells effectively.",
  "what_it_does_not_cover": [
    "Does not cover nanoparticle drug conjugates where the nanoparticle has an average diameter greater than 20 nanometers (Claim 1).",
    "Does not cover drug delivery systems where the drug is not attached to a nanoparticle via a cleavable linker (Claim 1).",
    "Does not cover methods of treating cancer that do not involve administering a nanoparticle drug conjugate designed to diffuse within tumor interstitium (Claim 1).",
    "Does not cover nanoparticles that are not specifically designed to carry a drug moiety (Claim 1).",
    "Does not cover treatments for conditions other than cancer (Claim 1)."
  ],
  "filed": "2023-12-19",
  "granted": null,
  "expires": "2043-12-19",
  "status": "active",
  "holder": "Cornell University",
  "holder_url": "https://patentbrief.org/company/cornell-university",
  "inventors": [
    {
      "name": "Jedd D. Wolchok",
      "url": "https://patentbrief.org/inventor/jedd-d-wolchok"
    },
    {
      "name": "Cameron Brennan",
      "url": "https://patentbrief.org/inventor/cameron-brennan"
    },
    {
      "name": "Michael Overholtzer",
      "url": "https://patentbrief.org/inventor/michael-overholtzer"
    },
    {
      "name": "Ulrich Wiesner",
      "url": "https://patentbrief.org/inventor/ulrich-wiesner"
    },
    {
      "name": "Michelle S. Bradbury",
      "url": "https://patentbrief.org/inventor/michelle-s-bradbury"
    },
    {
      "name": "Barney Yoo",
      "url": "https://patentbrief.org/inventor/barney-yoo"
    }
  ],
  "times_cited": 0,
  "tags": [
    "biotech",
    "pharmaceutical",
    "nanotechnology",
    "oncology",
    "drug_delivery"
  ],
  "abstract": "Described herein are nanoparticle conjugates that demonstrate enhanced penetration of tumor tissue (e.g., brain tumor tissue) and diffusion within the tumor interstitium, e.g., for treatment of cancer. Further described are methods of targeting tumor-associated macrophages, microglia, and/or other cells in a tumor microenvironment using such nanoparticle conjugates. Moreover, diagnostic, therapeutic, and theranostic (diagnostic and therapeutic) platforms featuring such nanoparticle conjugates are described for treating targets in both the tumor and surrounding microenvironment, thereby enhancing efficacy of cancer treatment. Use of the nanoparticle conjugates described herein with other conventional therapies, including chemotherapy, radiotherapy, immunotherapy, and the like, is also envisaged.",
  "url": "https://patentbrief.org/patent/us/20240408251/compositions-and-methods-for-targeted-particle-penetration-distribution-and-resp",
  "markdown_url": "https://patentbrief.org/patent/us/20240408251/compositions-and-methods-for-targeted-particle-penetration-distribution-and-resp/md",
  "google_patents_url": "https://patents.google.com/patent/US20240408251",
  "relatedPatents": [
    {
      "patentNumber": "20190046446",
      "countryCode": "US",
      "title": "How Special Nanoparticles Deliver Cancer Drugs Directly to Tumors",
      "url": "https://patentbrief.org/patent/us/20190046446/apo-e-modified-lipid-nanoparticles-for-drug-delivery-to-targeted-tissues-and-the"
    },
    {
      "patentNumber": "20190307892",
      "countryCode": "US",
      "title": "Targeting Drugs to Specific Body Tissues Using ApoE3-Coated Nanoparticles",
      "url": "https://patentbrief.org/patent/us/20190307892/targeted-drug-delivery-and-therapeutic-methods-using-apo-e-modified-lipid-nanopa"
    },
    {
      "patentNumber": "10307490",
      "countryCode": "US",
      "title": "Tiny Packages for Delivering Gene-Targeting Drugs to Specific Cells",
      "url": "https://patentbrief.org/patent/us/10307490/lipid-nanoparticle-compositions-for-antisense-oligonucleotides-delivery"
    },
    {
      "patentNumber": "9884123",
      "countryCode": "US",
      "title": "Targeted Platinum Drugs for Cancer Treatment",
      "url": "https://patentbrief.org/patent/us/9884123/ligand-targeted-molecules-and-methods-thereof"
    },
    {
      "patentNumber": "20240165159",
      "countryCode": "US",
      "title": "Targeting Cancer with CAR T Cells Using a Chemical Tag",
      "url": "https://patentbrief.org/patent/us/20240165159/compositions-and-methods-for-car-t-cell-therapy"
    }
  ]
}